Who Paid My Doc
VOYAGER P3 AD Vaccine Study
Research payments
$2,695,883
Through program year 2024, $2,695,883 in research payments was reported against VOYAGER P3 AD Vaccine Study, across 120 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $2,695,883 | 120 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Christopher Mancuso Nashua, NH Named on 4 payments
- Kevin Stein Winston Salem, NC Named on 3 payments
- Soheil Hekmat Inglewood, CA Named on 2 payments
- Manuel Sanchez Hialeah, FL Named on 2 payments
- Michael Lin Sherman Oaks, CA Named on 2 payments
- Jarad Levin Oklahoma City, OK Named on 2 payments
- Alton Walters North Las Vegas, NV Named on 2 payments
- Asra Ali Houston, TX Named on 2 payments
- Salma Saiger Mesquite, TX Named on 2 payments
- Judy Hu Hermitage, TN Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.